![Patrick Zenner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Zenner
Direttore/Membro del Consiglio presso
HealthCare Institute of New Jersey
Patrimonio netto: 77 915 $ in data 31/08/2026
Profilo
Patrick J. Zenner è un amministratore indipendente di Selecta Biosciences, Inc., un presidente non esecutivo di West Pharmaceutical Services, Inc. e un presidente della Fairleigh Dickinson University. Fa parte del consiglio di amministrazione di Selecta Biosciences, Inc., ArQule, Inc., Biotechnology Innovation Organization, HealthCare Institute of New Jersey e Creighton University. Il signor Zenner è stato precedentemente impiegato come direttore indipendente presso Par Pharmaceutical Cos., Inc., presidente e amministratore delegato di CuraGen Corp., presidente di EXACT Sciences Corp., presidente di ArQule, Inc., presidente e amministratore delegato di Hoffmann-La Roche, Inc., vicepresidente e direttore generale di Roche Laboratories, Inc. e presidente e amministratore delegato di Roche Holdings, Inc. È stato anche membro del consiglio di amministrazione di Sciele Pharma, Inc., XOMA Ltd., Dendrite International, Inc., Geron Corp., Endotis Pharma SARL, Neuro3D SA, NextWave Pharmaceuticals, Inc., Par Pharmaceutical, Inc., Pharmaceutical Research & Manufacturers of America e Praecis Pharmaceuticals, Inc. Si è laureato alla Creighton University e ha conseguito un MBA alla Fairleigh Dickinson University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,03% | 14/04/2026 | 8.396 ( 0,03% ) | 77 915 $ | 31/08/2026 |
Posizioni attive di Patrick Zenner
| Società | Posizione | Inizio |
|---|---|---|
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | Direttore/Membro del Consiglio | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direttore/Membro del Consiglio | - |
Creighton University
 Creighton University Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Patrick Zenner
| Società | Posizione | Fine |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Presidente | 24/05/2022 |
Endotis Pharma SARL
 Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Develops cardiovascular therapeutics | Direttore/Membro del Consiglio | 26/12/2013 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Direttore/Membro del Consiglio | 28/09/2012 |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Direttore/Membro del Consiglio | 01/01/2012 |
| ARQULE, INC. | Presidente | 01/01/2012 |
Formazione di Patrick Zenner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
23
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 23 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States | Health Technology |
Dendrite International, Inc.
 Dendrite International, Inc. Packaged SoftwareTechnology Services Provides sales force software products and support services | Technology Services |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
West Pharmaceutical Services, Inc.
 West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Roche Holdings, Inc.
 Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceuticals, diagnostic instruments, reagents & consumables | Health Technology |
EXACT Sciences Corp.
 EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Neuro3D SA
 Neuro3D SA Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products to treat the central nervous system | Health Technology |
Creighton University
Creighton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic drugs and pharmaceuticals products | Health Technology |
Endotis Pharma SARL
Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Develops cardiovascular therapeutics | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Markets and sells pharmaceutical medications | Distribution Services |
